for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Edap Tms SA (ADR)

EDAP.OQ

Latest Trade

4.52USD

Change

0.07(+1.57%)

Volume

114,912

Today's Range

4.36

 - 

4.74

52 Week Range

1.36

 - 

5.42

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
4.45
Open
4.36
Volume
114,912
3M AVG Volume
3.77
Today's High
4.74
Today's Low
4.36
52 Week High
5.42
52 Week Low
1.36
Shares Out (MIL)
29.00
Market Cap (MIL)
131.07
Forward P/E
25.19
Dividend (Yield %)
--

Next Event

Q3 2019 Edap Tms SA Earnings Release

Latest Developments

More

EDAP Reports Q2 Earnings Per Share Eur 0.05

EDAP TMS Pre-Announces Strong 98% Growth In HIFU Sales In The Second Quarter 2019

EDAP Qtrly Earnings Of EUR 0.01 Per Diluted Share

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Edap Tms SA (ADR)

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.

Industry

Medical Equipment & Supplies

Contact Info

Parc Activite

La Poudrette Lamartine

4/6 Rue du Dauphine

+33.4.72153150

https://www.edap-tms.com/

Executive Leadership

Philippe Chauveau

Independent Chairman of the Board

Marc Oczachowski

Chief Executive Officer and Director

Pierre Beysson

Independent Director

Robrecht L.W. Michiels

Independent Director

Argil J. Wheelock

Independent Director

Key Stats

2.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (EUR)

2016

0.130

2017

-0.020

2018

-0.010

2019(E)

0.160
Price To Earnings (TTM)
59.12
Price To Sales (TTM)
2.70
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

BRIEF-Edap Tms Q1 Revenue $11.3 Million

* Q1 REVENUE $11.3 MILLION Source text for Eikon: Further company coverage:

BRIEF-EDAP Reports First HIFU Treatments Performed At Acibadem Hospital, Istanbul

* EDAP'S FOCAL ONE® ROBOTIC HIFU TREATMENTS PERFORMED AT ACIBADEM HOSPITAL, ISTANBUL, TURKEY Source text for Eikon: Further company coverage:

BRIEF-EDAP signs exclusive agreement with Theraclion to distribute Echopulse® in France

* EDAP signs exclusive agreement with Theraclion to distribute Echopulse® HIFU product in France

BRIEF-Theraclion announces exclusive distribution agreement with EDAP TMS France

* THERACLION ANNOUNCES EXCLUSIVE DISTRIBUTION AGREEMENT WITH EDAP TMS FRANCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Edap announces FDA clearance of its Ablatherm-Fusion device

* Edap announces FDA clearance of its Ablatherm-Fusion® device

BRIEF-Edap Tms SA submits new 510(k) application for its Focal One device

* Edap Tms SA - company submitted a new 510(k) application for its focal one device, including an updated clinical section for FDA review Source text for Eikon: Further company coverage:

BRIEF-Edap announces filing of 510(k) application for Ablatherm-Fusion device

* Edap announces filing of 510(k) application for Ablatherm-Fusion device Source text for Eikon: Further company coverage:

BRIEF-Edap Tms SA reports Q1 earnings per share EUR 0.06

* Q1 revenue $9.3 million Source text for Eikon: Further company coverage:

BRIEF-Zenicor Medical Systems signs partnership deal with Technomed

* SAID ON THURSDAY IT SIGNED PARTNERSHIP DEAL WITH TECHNOMED LTD. IN GREAT BRITAIN

BRIEF-Edap sees Q4 2016 revenue 10.7 million euro

* Edap announces preliminary unaudited full year 2016 revenue

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up